<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371902</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT02371902</nct_id>
  </id_info>
  <brief_title>ESWT vs Cryo-US Therapy in the Treatment of Chronic Lateral Epicondylitis: One Year Follow up Study</brief_title>
  <official_title>Extracorporeal Shock Wave Therapy vs Cryoultrasound Therapy in the Treatment of Chronic Lateral Epicondylitis: One Year Follow up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic lateral epicondylitis is usually managed conservatively. The purpose of this
      single-blinded, randomized, controlled study is to compare the clinical therapeutic effects
      of extracorporeal shock wave therapy (ESWT) in comparison with cryoultrasound (Cryo-US)
      therapy in chronic lateral epicondylitis (LE) during a period of 12 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eighty participants with chronic LE were randomly assigned to receive 3 ESWT sessions at
      48/72-hours intervals -2400 impulses at energy flux density 0.14-0.20 mJ/mm2 at each session-
      (ESWT Group, n=40) or 12 Cryo-US therapy sessions (4 daily sessions per week) in a continuous
      modality at 1.8 Watt/cm2 and -2˚C at each session- (Cryo-US Group, n=40). Visual Analogue
      Scale (VAS) and satisfactory results, considered as the sum of the excellent and good scores
      in the Roles and Maudsley score, were used as outcome measures at baseline and 3, 6, and 12
      months post-treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference of two points in pain recorded on the VAS</measure>
    <time_frame>3, 6, or 12 months after the end of treatments</time_frame>
    <description>a difference of two points in pain recorded on the VAS during a maximum voluntary resisted isometric wrist extension with the elbow in extension (Cozen test), between the ESWT Group and the Cryo-US Group, in at least one of the periods taken into account.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients satisfaction based on the Roles and Maudsley score</measure>
    <time_frame>3, 6, or 12 months after the end of treatments</time_frame>
    <description>the number of patients who achieved at least 50% satisfactory results at 3, 6 and 12 months after the treatment. Satisfactory results were described as the sum of the excellent and good scores based on the Roles and Maudsley score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Tendinopathy</condition>
  <arm_group>
    <arm_group_label>ESWT Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Focused Extracorporeal Shock Wave Therapy: 3 sessions were carried out, with the time interval between sessions spanning between 48 and 72 hours. In each session, 2400 pulses were administered with energy flux density (EDF) ranging from 0.14 and 0.20 mJ/mm2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cryo-US Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapeutic cryoultrasound: 12 sessions was performed in a continuous emission modality, using an ultrasound emission power rating of 1,8 Watt/cm2, and a temperature of -2˚C, for a total of 12 sessions lasting 20 minutes each.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MODULITH® SLK, STORZ MEDICAL AG, Switzerland</intervention_name>
    <description>Three sessions were carried out, with the time interval between sessions spanning between 48 and 72 hours. In each session, 2400 pulses were administered with energy flux density (EDF) ranging from 0.14 and 0.20 mJ/mm2, depending on the maximum tolerated pain of each patient. Analgesics or local anaesthetics were not administered before, during or after treatment.</description>
    <arm_group_label>ESWT Group</arm_group_label>
    <other_name>Focused Extracorporeal Shock Wave Therapy</other_name>
    <other_name>ESWT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryoultrasound™, Medisport S.r.l., Italy</intervention_name>
    <description>Cryo-US therapy was performed in a continuous emission modality, using an ultrasound emission power rating of 1,8 Watt/cm2, and a temperature of -2˚C, for a total of 12 sessions lasting 20 minutes each. The treatment was performed in 3 weeks (4 daily sessions per week).</description>
    <arm_group_label>Cryo-US Group</arm_group_label>
    <other_name>Therapeutic Ultrasound</other_name>
    <other_name>Cryo-US therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  an age range from 18 to 75 years

          -  clinical or instrumental diagnosis of chronic lateral epicondylitis, present for at
             least three months

          -  intensity of pain of more than 5 on the Visual Analogue Scale (VAS) performing a
             maximum voluntary resisted isometric wrist extension with the elbow in extension
             (Cozen test)

          -  the failure of conservative treatments previously made

          -  a wash-out period of at least 12 weeks since the last conservative therapy carried out
             before inclusion in the study

          -  capability of filling in the questionnaires and signing the consent form

        Exclusion Criteria:

          -  Previous treatment with Cryo-US, ultrasound therapy, ESWT

          -  The conjoint presence of bilateral or lateral and medial epicondylitis

          -  Acute infection of the soft tissues or the bones adjacent to the area of treatment

          -  Local bleedings or skin lesions, pathologies of the blood coagulation, or use of
             anticoagulant drugs

          -  Pacemaker, pregnancy

          -  Neoplastic disease

          -  Raynaud's disease, altered thermal and pain sensitivity, or cold intolerance

          -  Evidence of elbow bursitis, or articular or synovial pathologies; signs of elbow
             laxity or instability

          -  Cervicobrachialgia; syndrome of ulnar, radial, or posterior interosseous nerve
             entrapment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria C Vulpiani, MD</last_name>
    <role>Study Chair</role>
    <affiliation>La Sapienza University of Rome</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sant'Andrea Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006 Dec 1;164(11):1065-74. Epub 2006 Sep 12.</citation>
    <PMID>16968862</PMID>
  </results_reference>
  <results_reference>
    <citation>Kraushaar BS, Nirschl RP. Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. J Bone Joint Surg Am. 1999 Feb;81(2):259-78. Review.</citation>
    <PMID>10073590</PMID>
  </results_reference>
  <results_reference>
    <citation>Galloway MT, Lalley AL, Shearn JT. The role of mechanical loading in tendon development, maintenance, injury, and repair. J Bone Joint Surg Am. 2013 Sep 4;95(17):1620-8. doi: 10.2106/JBJS.L.01004. Review.</citation>
    <PMID>24005204</PMID>
  </results_reference>
  <results_reference>
    <citation>Haahr JP, Andersen JH. Prognostic factors in lateral epicondylitis: a randomized trial with one-year follow-up in 266 new cases treated with minimal occupational intervention or the usual approach in general practice. Rheumatology (Oxford). 2003 Oct;42(10):1216-25. Epub 2003 Jun 16.</citation>
    <PMID>12810936</PMID>
  </results_reference>
  <results_reference>
    <citation>Dingemanse R, Randsdorp M, Koes BW, Huisstede BM. Evidence for the effectiveness of electrophysical modalities for treatment of medial and lateral epicondylitis: a systematic review. Br J Sports Med. 2014 Jun;48(12):957-65. doi: 10.1136/bjsports-2012-091513. Epub 2013 Jan 18. Review.</citation>
    <PMID>23335238</PMID>
  </results_reference>
  <results_reference>
    <citation>Vetrano M, d'Alessandro F, Torrisi MR, Ferretti A, Vulpiani MC, Visco V. Extracorporeal shock wave therapy promotes cell proliferation and collagen synthesis of primary cultured human tenocytes. Knee Surg Sports Traumatol Arthrosc. 2011 Dec;19(12):2159-68. doi: 10.1007/s00167-011-1534-9. Epub 2011 May 27.</citation>
    <PMID>21617986</PMID>
  </results_reference>
  <results_reference>
    <citation>Leone L, Vetrano M, Ranieri D, Raffa S, Vulpiani MC, Ferretti A, Torrisi MR, Visco V. Extracorporeal Shock Wave Treatment (ESWT) improves in vitro functional activities of ruptured human tendon-derived tenocytes. PLoS One. 2012;7(11):e49759. doi: 10.1371/journal.pone.0049759. Epub 2012 Nov 26.</citation>
    <PMID>23189160</PMID>
  </results_reference>
  <results_reference>
    <citation>Speed CA. Therapeutic ultrasound in soft tissue lesions. Rheumatology (Oxford). 2001 Dec;40(12):1331-6. Review.</citation>
    <PMID>11752501</PMID>
  </results_reference>
  <results_reference>
    <citation>Tsai WC, Pang JH, Hsu CC, Chu NK, Lin MS, Hu CF. Ultrasound stimulation of types I and III collagen expression of tendon cell and upregulation of transforming growth factor beta. J Orthop Res. 2006 Jun;24(6):1310-6.</citation>
    <PMID>16705693</PMID>
  </results_reference>
  <results_reference>
    <citation>Costantino C, Pogliacomi F, Vaienti E. Cryoultrasound therapy and tendonitis in athletes: a comparative evaluation versus laser CO2 and t.e.ca.r. therapy. Acta Biomed. 2005 Apr;76(1):37-41.</citation>
    <PMID>16116824</PMID>
  </results_reference>
  <results_reference>
    <citation>Costantino C, Vulpiani MC, Romiti D, Vetrano M, Saraceni VM. Cryoultrasound therapy in the treatment of chronic plantar fasciitis with heel spurs. A randomized controlled clinical study. Eur J Phys Rehabil Med. 2014 Feb;50(1):39-47. Epub 2013 Oct 30.</citation>
    <PMID>24172641</PMID>
  </results_reference>
  <results_reference>
    <citation>Chung B, Wiley JP, Rose MS. Long-term effectiveness of extracorporeal shockwave therapy in the treatment of previously untreated lateral epicondylitis. Clin J Sport Med. 2005 Sep;15(5):305-12.</citation>
    <PMID>16162988</PMID>
  </results_reference>
  <results_reference>
    <citation>Radwan YA, ElSobhi G, Badawy WS, Reda A, Khalid S. Resistant tennis elbow: shock-wave therapy versus percutaneous tenotomy. Int Orthop. 2008 Oct;32(5):671-7. Epub 2007 Jun 6.</citation>
    <PMID>17551726</PMID>
  </results_reference>
  <results_reference>
    <citation>Rompe JD, Decking J, Schoellner C, Theis C. Repetitive low-energy shock wave treatment for chronic lateral epicondylitis in tennis players. Am J Sports Med. 2004 Apr-May;32(3):734-43.</citation>
    <PMID>15090392</PMID>
  </results_reference>
  <results_reference>
    <citation>Day B. 'Extracorporeal shock wave therapy for lateral epicondylitis--a double blind randomised controlled trial', by Speed CA, Nichols D, Richards C, Humphreys H, Wies JT, Burnet S, Hazleman BL [Journal of Orthopaedic Research 29 (2002) 895-898]. J Orthop Res. 2003 Sep;21(5):960; author reply 961.</citation>
    <PMID>12919888</PMID>
  </results_reference>
  <results_reference>
    <citation>Rompe JD, Overend TJ, MacDermid JC. Validation of the Patient-rated Tennis Elbow Evaluation Questionnaire. J Hand Ther. 2007 Jan-Mar;20(1):3-10; quiz 11.</citation>
    <PMID>17254903</PMID>
  </results_reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2015</study_first_submitted>
  <study_first_submitted_qc>February 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2015</study_first_posted>
  <last_update_submitted>February 19, 2015</last_update_submitted>
  <last_update_submitted_qc>February 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Mario Vetrano, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Elbow pain</keyword>
  <keyword>lateral epicondylitis</keyword>
  <keyword>conservative treatment</keyword>
  <keyword>shock wave treatment</keyword>
  <keyword>therapeutic ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

